Amarin Corp Plc (AMRN)

[Biobillionair]

Pacer update: Note trial starts at 8:30 again tomorrow...but today was short for whatever reasons discussed....

Dr. Peter Toth plaintiff witness

Today’s minutes:
Case 2:16-cv-02525-MMD-NJK Document 356 Filed 01/27/20 Page 1 of 2
AMARIN PHARMA INC., Plaintiffs,
VS.
HIKMA PHARMACEUTICALS AND DR. REDDY’S LABORATORIES (DRL),
Defendants,
2:16-CV-2525-MMD-NJK MINUTES OF PROCEEDINGS
UNITED STATES DISTRICT COURT DISTRICT OF NEVADA
DATED:
January 27, 2020
PRESENT:
THE HONORABLE MIRANDA M. DU, U.S. DISTRICT JUDGE
DEPUTY CLERK: PEGGIE VANNOZZI COURT REPORTER: KATHY FRENCH
COUNSEL FOR PLAINTIFFS: Megan Keane, Christopher Sipes, Michael Kennedy, Jeffrey Ellikan, Alaina Whitt, Han
Park, Daniel Farnolly, Eric Sonnenschein
COUNSEL FOR DEFENDANT HIKMA: Charles Klein, Eimeric Reig-Plessis, W. West Allen, Claire Fundakowski, Allison Heydorn
COUNSEL FOR DEFENDANT DRL: Constance Huttner, Michael Rounds, Caroline Sun
IN COURT PROCEEDINGS: Bench trial, day 6
Proceedings begin at 8:31 AM. Also present for Amarin: Joseph Kennedy as corporate representative, Barbara Kurys as patent counsel and Litigation Support Technician David Brooks. Also present for Defendants: Neema Kumar as corporate representative for Hikma, Andrew Allen and Deeph Jain as corporate representatives for DRL and Litigation Support Technician Stephen Gros.
Peter Paul Toth is sworn to testify. Mr. Elikan examines the witness. Plaintiff’s exhibit 1172 is marked and admitted. The witness is qualified as an expert in the areas of Lipidology treatment, Triglycerideremia, Hypertriglicyeridemia, Severe
1 2:16-cv-2525-MMD-NJK Amarin Pharma vs. Hikma, DRL, January 27, 2020

Case 2:16-cv-02525-MMD-NJK Document 356 Filed 01/27/20 Page 2 of 2
Hypertriglyceridemia and preventive cardiovascular disease. PDX 6-7 is admitted as a summary demonstrative exhibit under FRE 1006. Plaintiff’s exhibits 883, 852, 866, 959, 875, 952, 902, and 714 are marked and admitted.
Recess: 10:32 AM – 11:21 AM.
Direct examination of Peter Toth resumes. PDX 6-8 is admitted as a summary demonstrative exhibit under FRE 1006.
Recess: 1:05 PM – 2:24 PM
Direct examination of Peter Toth resumes. Plaintiff’s exhibits 833, 936, 961, 948, 949, 492, 956, 938, 930, 953 and 954 are marked and admitted. PDX 6-29 is admitted as a summary demonstrative exhibit under FRE 1006.
The Court and counsel discuss scheduling.
The bench trial is continued to Tuesday, January 28, 2020 at 8:30 AM in Reno Courtroom 5 before Chief Judge Miranda M. Du.
Recess: 3:38 PM.
DEBRA K. KEMPI, CLERK
U.S. District Court By: Peggie Vannozzi Deputy Clerk
2 2:16-cv-2525-MMD-NJK Amarin Pharma vs. Hikma, DRL, January 27, 2020